219 results on '"Seiler"'
Search Results
2. Molecular characterization of neuroendocrine-like bladder cancer
3. Evaluation of sarcopenia in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A study from the Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology
4. Combining DNA-repair gene mutations and molecular subtyping for more accurate prediction of outcome after neoadjuvant chemotherapy for bladder cancer
5. Molecular decoding of sarcomatoid variant of muscle-invasive bladder cancer might reveal treatment strategies
6. Predictive value and potentials for co-targeted therapy of STAT1 signaling in gemcitabine/cisplatin resistant bladder cancer
7. The genomic landscape of muscle-invasive bladder cancer enables a personalized in silico drug discovery
8. Risk stratification of high-risk prostate cancer based on MR prostate imaging for clinical practice and implementation in computer-aided software systems
9. Independent multicenter validation of the prognostic significance of histopathologic tumor regression grade after neoadjuvant chemotherapy in bladder cancer
10. Molecular characterization of neuroendocrine-like bladder cancer
11. Evaluation of sarcopenia in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A study from the Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology
12. Urothelial carcinoma in bladder diverticula: A multicenter analysis of characteristics and treatment outcome in 110 patients
13. Cigarette smoking is adversely associated with pathological response to platinum-based neoadjuvant chemotherapy in patients undergoing treatment for urinary bladder cancer
14. The impact of cigarette smoking on adverse pathological features and survival in patients undergoing radical cystectomy for urinary bladder cancer - a prospective, European multicenter study of the EAU young academic urologists urothelial carcinoma group
15. Biological characterization of cisplatin-resistant bladder cancer: Implications for second-line treatments?
16. Postoperative chemotherapy bladder instillation after nephroureterectomy: A survey from the YAU urothelial cancer group and ESOU
17. The genomic landscape of muscle-invasive bladder cancer enables a personalized in silico drug discovery
18. Combining DNA-repair gene mutations and molecular subtyping for more accurate prediction of outcome after neoadjuvant chemotherapy for bladder cancer
19. Predictive value and potentials for co-targeted therapy of STAT1 signaling in gemcitabine/cisplatin resistant bladder cancer
20. Risk stratification of high-risk prostate cancer based on MR prostate imaging for clinical practice and implementation in computer-aided software systems
21. Urothelial carcinoma in bladder diverticula: A multicenter analysis of characteristics and treatment outcome in 110 patients
22. Postoperative chemotherapy bladder instillation after nephroureterectomy: A survey from the YAU urothelial cancer group and ESOU
23. Cigarette smoking is adversely associated with pathological response to platinum-based neoadjuvant chemotherapy in patients undergoing treatment for urinary bladder cancer
24. Biological characterization of cisplatin-resistant bladder cancer: Implications for second-line treatments?
25. The impact of smoking on genomic alterations in muscle-invasive bladder cancer
26. The impact of cigarette smoking on adverse pathological features and survival in patients undergoing radical cystectomy for urinary bladder cancer - a prospective, European multicenter study of the EAU young academic urologists urothelial carcinoma group
27. Her2 alterations in muscle-invasive bladder cancer: There is more than protein expression in patient selection for targeted therapy
28. Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy
29. The impact of smoking on genomic alterations in muscle-invasive bladder cancer
30. Her2 alterations in muscle-invasive bladder cancer: There is more than protein expression in patient selection for targeted therapy
31. Tumor regression grading after neoadjuvant chemotherapy in bladder cancer: Validation in an independent cohort
32. Clinical and outcome characteristics of the cancer genome atlas (TCGA) bladder cancer cohort: Is it representative?
33. T-DM1, a novel HER2 antibody-cytotoxic drug conjugate, has anti-metastatic potential and is a promising targeted therapy for bladder cancer with HER2 IHC score 2+/3+
34. Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy
35. PT147 - Risk stratification of high-risk prostate cancer based on MR prostate imaging for clinical practice and implementation in computer-aided software systems
36. 1117 - Combining DNA-repair gene mutations and molecular subtyping for more accurate prediction of outcome after neoadjuvant chemotherapy for bladder cancer
37. 1073 - Molecular decoding of sarcomatoid variant of muscle-invasive bladder cancer might reveal treatment strategies
38. 738 - Evaluation of sarcopenia in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A study from the Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology
39. 174 - Predictive value and potentials for co-targeted therapy of STAT1 signaling in gemcitabine/cisplatin resistant bladder cancer
40. T-DM1, a novel HER2 antibody-cytotoxic drug conjugate, has anti-metastatic potential and is a promising targeted therapy for bladder cancer with HER2 IHC score 2+/3+
41. Clinical and outcome characteristics of the cancer genome atlas (TCGA) bladder cancer cohort: Is it representative?
42. Tumor regression grading after neoadjuvant chemotherapy in bladder cancer: Validation in an independent cohort
43. 929 Targeting lactate transporters for the treatment of urothelial carcinoma
44. 508 The impact of cigarette smoking and smoking cessation on oncological aggressiveness at radical cystectomy – a prospective, European, multicenter study of the EAU Young Academic Urologists (YAU) bladder cancer working group
45. 719 Percutaneous transluminal angioplasty for treatment of transplant renal artery stenosis
46. 1046 Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma
47. 1145 Predicting response to neoadjuvant cisplatin chemotherapy in bladder cancer with a novel gene expression signature
48. 216 Discrepancy between guidelines and daily practice in the management of non-muscle-invasive bladder cancer (NMIBC): Results of a European survey
49. 927 Effective treatment of cisplatin-resistant bladder cancer using a glycosaminoglycan binding malaria protein
50. 925 STAT1 inhibition restored chemotherapy sensitivity in cisplatin/gemcitabine resistant bladder cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.